These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7790095)

  • 21. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
    Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
    Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative immunomorphological study of the immunogenic activity of dysentery vaccines produced by different methods].
    Belaia IuA; Rukhamina ML; Nguyen ZH
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):64-70. PubMed ID: 6353818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
    J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates.
    Robbins JB; Kubler-Kielb J; Vinogradov E; Mocca C; Pozsgay V; Shiloach J; Schneerson R
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7974-8. PubMed ID: 19346477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
    Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
    Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome analysis to detect potential vaccine-induced changes on Shigella sonnei genome.
    Behar A; Fookes MC; Goren S; Thomson NR; Cohen D
    Vaccine; 2015 Jun; 33(26):2978-83. PubMed ID: 25936664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral immunization with Shigella ribosomal vaccine elicits local IgA response and primes for mucosal memory.
    Levenson VI; Chernokhvostova EV; Lyubinskaya MM; Salamatova SA; Dzhikidze EK; Stasilevitch ZK
    Int Arch Allergy Appl Immunol; 1988; 87(1):25-31. PubMed ID: 3049397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
    Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
    Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
    Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trial of the protective activity of ribosomal Sonne vaccine in monkeys].
    Levenson VI; Dzhikidze EK; Stasilevich ZK; Kavtaradze KN; Subbotina IuL
    Vestn Akad Med Nauk SSSR; 1986; (3):69-72. PubMed ID: 3518271
    [No Abstract]   [Full Text] [Related]  

  • 36. Laboratory control of oral Shigella sonnei vaccine.
    Starke G; Thilo W
    Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
    [No Abstract]   [Full Text] [Related]  

  • 37. [A protective factor of ribosomal shigellosis vaccine].
    Levenson VI; Rukhadze EZ; Egorova TP; Belkin ZP; Fedosova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jul; (7):50-4. PubMed ID: 3055762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective milk O antibodies induced in guinea pigs by parenteral Shigella ribosomal vaccine.
    Chernokhvostova EV; Lyubinskaya MM; Belkin ZP; Levenson VI
    Int Arch Allergy Appl Immunol; 1990; 92(3):265-7. PubMed ID: 2276843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.